ICU feeding showdown: continuous vs intermittent – which is better for recovery?
NCT ID NCT07173504
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving tube feeding in four daytime portions (intermittent) is better than the standard 24-hour continuous drip for critically ill patients in the ICU. Researchers will track blood sugar control, gut function, sleep quality, and muscle loss in 124 adults over up to 5 days. The goal is to find a feeding pattern that improves metabolic health without harming recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intermittent enteral nutrition (tube feeding given in four 1-hour daytime portions)
What this could lead to
If it works, this could point toward a better feeding schedule for ICU patients, potentially improving blood sugar control and recovery.
What could go wrong
This is a small, early-stage study (124 people) looking at short-term effects over only 5 days. Results may not apply to all ICU patients or lead to clear changes in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Deventer Ziekenhuis
RECRUITINGDeventer, Overijssel, 7416 SE, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Gelderse Vallei Hospital
RECRUITINGEde, Gelderland, 6716 RP, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Haga Ziekenhuis
RECRUITINGThe Hague, South Holland, 2545 AA, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Martini Ziekenhuis
RECRUITINGGroningen, Provincie Groningen, 9728NT, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medisch Spectrum Twente
RECRUITINGEnschede, Overijssel, 7512KZ, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••